Edition:
United Kingdom

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

4.25USD
23 May 2018
Change (% chg)

$-0.20 (-4.49%)
Prev Close
$4.45
Open
$4.40
Day's High
$4.45
Day's Low
$4.25
Volume
10,846
Avg. Vol
26,049
52-wk High
$6.10
52-wk Low
$2.30

Chart for

About

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $130.63
Shares Outstanding(Mil.): 34.84
Dividend: --
Yield (%): --

Financials

  HBIO.OQ Industry Sector
P/E (TTM): -- 148.43 32.75
EPS (TTM): -0.13 -- --
ROI: -4.52 9.37 14.38
ROE: -5.80 14.69 16.07

BRIEF-Harvard Bioscience Q1 GAAP Loss Per Share $0.11

* HARVARD BIOSCIENCE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

02 May 2018

BRIEF-Harvard Bioscience Inc Files For Mixed Shelf Of Up To $50 Mln

* HARVARD BIOSCIENCE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Source text (https://bit.ly/2KqwbVG) Further company coverage:

30 Apr 2018

BRIEF-Harvard Bioscience Reports Q4 GAAP Earnings Per Share $0.03

* HARVARD BIOSCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 RESULTS

01 Mar 2018

BRIEF-Harvard Bioscience Says Co Entered Into A Financing Agreement

* HARVARD BIOSCIENCE INC - ON JAN 31, 2018, CO ENTERED INTO A FINANCING AGREEMENT - SEC FILING

02 Feb 2018

BRIEF-Harvard Bioscience To Acquire Data Sciences International

* HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC

22 Jan 2018

Earnings vs. Estimates